Mardi C. Dier
2018
In 2018, Mardi C. Dier earned a total compensation of $2.5M as Executive Vice President, Chief Financial and Business Officer at Portola Pharmaceuticals, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $197,800 |
|---|---|
| Option Awards | $1,264,987 |
| Salary | $505,000 |
| Stock Awards | $545,169 |
| Other | $8,250 |
| Total | $2,521,206 |
Dier received $1.3M in option awards, accounting for 50% of the total pay in 2018.
Dier also received $197.8K in non-equity incentive plan, $505K in salary, $545.2K in stock awards and $8.3K in other compensation.
Rankings
In 2018, Mardi C. Dier's compensation ranked 4,626th out of 14,244 executives tracked by ExecPay. In other words, Dier earned more than 67.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,626 out of 14,244 | 68th |
Division Manufacturing | 1,740 out of 5,759 | 70th |
Major group Chemicals And Allied Products | 627 out of 2,122 | 71st |
Industry group Drugs | 525 out of 1,811 | 71st |
Industry Pharmaceutical Preparations | 405 out of 1,385 | 71st |
Source: SEC filing on April 19, 2019.
Dier's colleagues
We found six more compensation records of executives who worked with Mardi C. Dier at Portola Pharmaceuticals in 2018.
2018
Scott Garland
Portola Pharmaceuticals
Chief Executive Officer
2018
William Lis
Portola Pharmaceuticals
Chief Executive Officer
2018
John Moriarty
Portola Pharmaceuticals
General Counsel
2018
Glenn Brame
Portola Pharmaceuticals
Executive Vice President, Chief Technical Operations Officer
2018
Ernie Meyer
Portola Pharmaceuticals
Chief Human Resources Officer
2018
John Curnutte
Portola Pharmaceuticals